Anti‐γ‐aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights
Epilepsia · 2026-01 · 67 (1) · 187-198
DOI: 10.1111/epi.18654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 30.09.2025. Verfasst von Naveen K Paramasivan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Receptors, GABA-B, Encephalitis, Autoantibodies, Hashimoto Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Objectives γ‐Aminobutyric acid B receptor (GABA B R)‐IgG (immunoglobulin G) is an intermediate‐risk paraneoplastic autoantibody often associated with seizures. We aimed to assess the clinical and oncological features of GABA B R‐IgG autoimmune encephalitis (AE) and evaluate the performance of antibody testing.
Methods
Patients testing positive for GABA B R‐IgG in serum/cerebrospinal fluid (CSF) at Mayo Clinic Neuroimmunology Laboratory were identified. Archived sera were retested by cell‐based assay (CBA) at 1:100 and 1:200 dilutions. A live‐cell flow cytometry–based assay (LCFBA) was developed and validated using archived sera and CSF. True positivity included patients with classic presentations of GABA B R‐IgG AE or oncological explanations for antibody presence.
Results
Eighty‐six patients (median age 63 years; 43 female) presented with classic presentations of GABA B R‐IgG AE: encephalopathy with prominent seizures ( n = 55), status epilepticus ( n = 23), and rapidly progressive dementia ( n = 8). In addition, 44 patients (33%) had a false‐positive result for GABA B R‐IgG characterized by non‐specific symptoms/alternate diagnoses. Malignancy was identified in 78% of true‐positive patients, predominantly small cell lung carcinoma (SCLC). Testing serum at 1:100 dilution on CBA and using tissue immunofluorescence assay (IFA) in serum and CSF improved the identification of true‐positive patients ( p < 0.001). CBA at 1:100 dilution performed better than conventional CBA (at 1:10 dilution, p < 0.001) and tissue IFA ( p = 0.031). An in‐house LCFBA showed 100% sensitivity and specificity in CSF, performing similarly to conventional CBA ( p = 0.125) in CSF, but better than tissue IFA ( p = 0.031). Furthermore, serum LCFBA performed better than conventional CBA ( p = 0.022) and tissue IFA ( p = 0.006). LCFBA had the highest diagnostic accuracy and was closely followed by CBA at 1:100 dilution. Significance GABA B R‐IgG AE often presents as encephalopathy with seizures or status epilepticus in the context of an underlying SCLC. Multimodal evaluation using tissue IFA and fixed CBA at higher dilutions improves detection of true cases. LCFBA performs very well as a diagnostic test with very high sensitivity and specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Epilepsy Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
ORCID-Profile: Naveen K Paramasivan, Jennifer A McCombe, Andrea Stabile, Abhigyan Datta, Jeffrey W Britton, Eoin P Flanagan, Andrew McKeon, John R Mills, Sean J Pittock, Anastasia Zekeridou, Divyanshu Dubey
Förderung
- NINDS NIH HHS
Zitieren
APA
Paramasivan, N. K., McCombe, J. A., Stabile, A., Fryer, J. P., Datta, A., Rezk, M., Upadhyay, N., Britton, J. W., Flanagan, E. P., McKeon, A., Mills, J. R., Pittock, S. J., Zekeridou, A., & Dubey, D. (2026). Anti‐γ‐aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights. Epilepsia, 67(1), 187-198. https://doi.org/10.1111/epi.18654
Vancouver
Paramasivan NK, McCombe JA, Stabile A, Fryer JP, Datta A, Rezk M, et al. Anti‐γ‐aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights. Epilepsia. 2026;67(1):187-198. doi:10.1111/epi.18654
BibTeX
@article{Paramasivan2026,
author = {Paramasivan, Naveen K and McCombe, Jennifer A and Stabile, Andrea and Fryer, James P and Datta, Abhigyan and Rezk, Mohamed and Upadhyay, Nihar and Britton, Jeffrey W and Flanagan, Eoin P and McKeon, Andrew and Mills, John R and Pittock, Sean J and Zekeridou, Anastasia and Dubey, Divyanshu},
title = {Anti‐γ‐aminobutyric acid B receptor autoimmune encephalitis: Clinical presentation and diagnostic insights},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {1},
pages = {187--198},
doi = {10.1111/epi.18654}
}
EUVIMED